SPONSOR
Berlin-Chemie AG Menarini Group
Total Trials
2
Recruiting
2
Phases
Phase 1
Berlin-Chemie AG Menarini Group is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Healthy Volunteer Male Subjects, Healthy Adult Male and Female Volunteers.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Berlin-Chemie AG Menarini Group
How many clinical trials has Berlin-Chemie AG Menarini Group sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Berlin-Chemie AG Menarini Group, of which 2 are actively recruiting participants. These trials cover conditions including Healthy Volunteer Male Subjects, Healthy Adult Male and Female Volunteers. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Berlin-Chemie AG Menarini Group research focus on?
Berlin-Chemie AG Menarini Group clinical trials span Healthy Volunteer Male Subjects, Healthy Adult Male and Female Volunteers. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Berlin-Chemie AG Menarini Group clinical trial?
To participate in a Berlin-Chemie AG Menarini Group trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Berlin-Chemie AG Menarini Group trials with current recruitment status updated daily.
Clinical Trials by Berlin-Chemie AG Menarini Group
NCT07156916 Phase 1
Recruiting
A Comparative Bioavailability Study of Tamsulosin 0.4 mg Prolonged-release Tablets Versus the Reference Drug Omnic Ocas®, Tamsulosin Hydrochloride 0.4 mg, Prolonged-release Film-coated Tablets, in Healthy Adult Male Subjects, Under Fasting Conditions
Healthy Volunteer Male Subjects
NCT07201584 Phase 1
Recruiting
A Comparative Bioavailability Study of Two Torasemide 10 mg Tablets Formulations in Healthy Adult Participants Under Fasting Conditions:
Healthy Adult Male and Female Volunteers
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology